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The nonobese diabetic (NOD)' mouse provides a relevant model for insulin-
dependent diabetes mellitus (IDDM) . SpontaneousIDDM is usuallyobserved after
12 wk of age and largely predominates in females (1) . The role of autoimmune
phenomenain thedestruction of islet (3 cells in this model is indicatedby islet infiltration
by mononuclear cells, mainly Tlymphocytes (2, 3), by prevention ofIDDM by neo-
natal thymectomy (4), and by in vivo treatment with cyclosporine A (5), anti-CD4+
(6, 7), or anti-I-A mAbs (8) . In addition, adoptive transfer of overt diabetes has re-
cently been obtained both in healthyNOD neonates (9) and in pre-irradiated adult
male recipients (10, 11)by injectionofspleen cells collected from diabeticNODmice .
The need for irradiation in order to render nondiabetic adult NOD mice suscep-
tible to diabetes transfer appears around 5 wk of age in females and around 3 wk
of age in males (9) . Diabetes transfer depends in both models on the simultaneous
presence ofCD4+ and CD8 + cells (9, 11) . The role of T cells is further underlined
by the predominance of Thy-1,2+ cells in islet infiltrates (3), the absence ofdiabetes
inNOD nu/nu mice (12), and by efficient transfer of the disease in B cell-deprived
recipients (13) . Finally, it is worth noting that theNODmouse disease shows apoly-
genic susceptibility that includes clear genetic linkage with genes mapping within
the MHC (14-17) .
The role of regulatoryT cells in the development ofantipancreatic autoimmunity
remains unclear. Induction of early diabetes in young male as well as femaleNOD
mice by injections ofcyclophosphamide (18) and the requirement forthe pre-irradiation
mentioned above to transfer IDDM into adult recipients (10), suggested a role of
suppressive immune phenomenawhosenature hasremained elusive in other systems.
The adoptive transfer model provides a sensitive assay for further establishing
the existence of such suppressive phenomena and studying their mechanisms . In
this study, we bring direct evidence for suppressor cells that inhibit the transfer of
diabetes in 8-wk-old pre-irradiated NOD recipients . We show that suppressor cells
in this model are age and sex dependent, are CD4+ cells, and are abrogated by
thymectomy at 3 wk of age .
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Materials and Methods
Mice.
￿
NOD mice were bred in our facilities under specific pathogen-free conditions. The
spontaneous incidence of diabetes in our colony reaches 38.6% in females and 0% in males
by 6 mo of age. In all experiments, mice were monitored for glycosuria three times a week
(Glukotest; Boehringer-Mannheim, Mannheim, FRG) . Glycosuric mice and all mice at the
end of each experimental procedure were checked for fasting glycemia by using test strips
and a colorimetric assay (Haemoglucotest and Reflolux F; Boehringer-Mannheim). Diabetes
was diagnosed when permanent fasting glycernia above 3 g/liter occurred. Hybridoma lines
4.221, 3 .155, 172.4, 30-H12, 53-6.7, and GK 1 .5 were grown in the form of ascites in Swiss
nude mice purchased from Iffa-Credo (IArbresle, France), as previously described (9).
Adoptive Transfer ofDiabetes.
￿
Recipients were preirradiated (750 rad) 8-wk-old male NOD
mice, except in one experiment in which 8-wk-old female recipients were used. The transfer
of diabetes was performed by injecting intravenously 10' spleen cells from diabetic mice in
the recipients irradiated 48 h earlier (10), the spleen cells from overtly diabetic NOD mice
being prepared aseptically in HBSS and pooled before transfer.
Passive Transfer ofProtective Spleen Cells.
￿
Thymic and spleen cells were collected from male
and female nondiabetic NOD mice of various ages. They were prepared aseptically in HBSS
and pooled within each age range or experimental group, then injected intravenously (20
x 106 cells per recipient mouse) either unmodified or after lymphocyte depletions with var-
ious mAbs as described below.
Cell Fractionations.
￿
Rat mAbs used for cell depletion were obtained from clone 4.221 for
Thy 1.2' cells, clone 3.155 for CD8' cells, and clone 172.4 for CD4' cells as previously de-
scribed (9). Depletion of Thy-1.2' cells, CD4' cells, or CD8' cells was performed by in-
cubating spleen cells at a density of 2 x 107 cells/ml with relevant mAbs in the form of as-
cites diluted 1 :200 in HBSS for 45 min at 4°C, then, after washing, with rabbit complement
(Cedarlane Laboratories Ltd., Ontario, Canada) diluted 1 :10 in HBSS for 45 min at 37'C.
Treated cells were washed three times and injected into experimental animals asdescribed above.
Monitoring ofPurled Subpopulations.
￿
Purified subpopulations were phenotyped by mem-
brane fluorescence analysis using fluorescein-conjugated Fab fragments of sheep anti-mouse
Ig (Biosys, Compiegne, France) for membrane Ig' cells, and fluorescein-conjugated purified
antibodies from hybridoma 30-H 12 for Thy 1.2' cells, 53-6.7 for CD8' cells, and GK 1.5
for CD4' cells. Since 30-H 12 and 53-6.7 compete respectively with 4.221 and 3.155 for im-
munofluorescence staining, a fluorescein-conjugated mouse anti-ic mAb specific for rat light
chain (Byosis) was used to detect cells that might have escaped lysis by complement despite
fixation of IgMrc mAbs 4.221 or 3.155 (9). In all depletion experiments, <1° Jo residual cells
counted among 3-4 x 102 total cells were stained with either the mAb corresponding to the
depleted subset or the anti-rc light chain antibody.
Histopathology.
￿
Paraffin sections (2 pM) of bouin-fixed pancreases were stained with he-
matoxylin and eosin. 16-81 islets of Langerhans were examined for each pancreas specimen.
Insulitis was evaluated as the percentage of islets showing a lymphoid infiltrate within or
around the islets.
Thymectomy.
￿
Thymectomy was performed at weaning (3 wk of age) by aspiration under
anesthesia with Nembutal.
Statistical Analysis.
￿
Statistical analyses were performed using Student's t test, the X2 test
or the Dunnet test when necessary. Histological data were analyzed using the U test of Mann
and Whitney.
Results
Protection Against Diabetes Transfer by Spleen Cellsfrom Nondiabetic NOD Mice.
￿
To
evaluate the protective effect oflymphoid cells from nondiabetic NOD mice against
diabetes development upon transfer of the disease, irradiated NOD recipients were
reconstituted with lymphoid cells collected from nondiabetic NOD donors 24 h be-
fore the transfer of diabetogenic cells collected from diabetic NOD mice. All recip-
ient animals were indeed 8-wk-old irradiated (750 rad) NOD mice that were adop-BOITARD ET AL .
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tively transferred 48 h after irradiation with 10' diabetogenic spleen cells collected
from recently diabetic NOD female mice .
As shown in Fig. 1, all control, unreconstituted animals developed overt diabetes
within 4 wk after the transfer. The delay in diabetes onset upon transfer did not
significantly differ when comparing female (3 .1 t 0.2 wk, SE) to male (3 .1 ± 0.4
wk, SE) recipients . Reconstitution of preirradiated male NOD recipients with 20
x 106 spleen cells from nondiabetic 8-wk-old male or female NOD mice sig-
nificantly delayed theonset of clinical diabetes afterthetransfer ofdiabetogenic spleen
cells . This delay was more pronounced after reconstitution with spleen cells from
female (10.8 t 1.6 wk, SE, p < 0.001) than male nondiabetic donors (6.8 ± 1 .3 wk,
SE,p< 0.01) although maleNOD mice show alower susceptibility than female mice
to spontaneousdiabetes in all known colonies includingourown. Importantly, spleen
cells from 8-wk-old maleNODmice delayed theonset ofdiabetes in male recipients.
The same experimental protocol was applied to preirradiated female NOD re-
cipients . A significant delay in diabetes onset after transfer of diabetogenic spleen
cells was observed in female recipients reconstituted with spleen cells from 8-wk-old
nondiabetic female (5.2 t 0.7 wk, SE, p< 0.05) but not male (4.3 t 0.8 wk, SE)
NOD donors (Fig. 1) . Noticeably, the delay in diabetes onsetwas of shorterduration
in female than in male recipients, possibly due to higher susceptibility of female
than male NOD mice to diabetes . Male 8-wk-old NOD recipients were used in all
further experiments in orderto avoid the possible interference ofdisease transferred
by diabetogenic spleen cell with spontaneous disease in female recipients .
Protection Against the Transfer of Insulitis.
￿
Histological examination of pancreatic
sections from preirradiated male recipients reconstituted with spleen cells from non-
diabetic 8-wk-old female donors showed no protection against insulitis either at 9
or 16 d after the transfer ofdiabetogenic spleen cells (Table I). Interestingly, insulitis
FIGURE 1 .
￿
Incidence of successful transfer of diabetes into irradiated (750 rad) 8-wk-old male
(solid lines) or female (dottedlines) recipients injected intravenously with 20 x 106 spleen cells col-
lected from 8-wk-old nondiabetic male (O, ") or female (A, A) NOD donors 24 h before the
transfer of 107 diabetogenic spleen cells . Two other groups of8-wk-old recipients (it, *) received
no spleen cells from nondiabetic donors, but received 107 diabetogenic spleen cells 48 h after
irradiation. Numbers next tolines indicate thenumber ofdiabetic recipients overthe totalnumber
of animals in each experimental group .1672
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TABLE I
Absence of Protective Activity of Spleen Cells from
Nondiabetic NOD Mice against Insulitis
Percent of islets showing insulitis'
9 d after transfer
￿
16 d after transfer
mean (range)
￿
mean (range)
No spleen cellst
￿
2.1 (0-4.2)
￿
2 .0 (0-6)
n = 2
￿
n = 3
Diabetogenic spleen cells§
￿
5.7 (0-12)
￿
88.7 (62-100)
n = 5
￿
n = 5
Protectivell + diabetogenic
￿
31.3 (3-80)
￿
98.7 (93-100)
spleen cells
￿
n = 4
￿
n = 5
Mean percent ofislets showing insulitis; nindicates the number ofanimals in each experimental
group.
Control 8-wk-old irradiated (750 rad) male recipients that received no protective and no dia-
betogenic spleen cells.
§ Diabetogenic spleen cells (107) collected from recently diabetic female NOD mice.
n Protective spleen cells (20 x 106) collected from 8-wk-old nondiabetic female NOD mice .
was cleared up in recipients that were not reconstituted with spleen cells from non-
diabetic donors nor transferred with diabetogenic spleen cells.
Age Dependency of the Protective Activity ofSpleen Cellsfrom Nondiabetic Mice.
￿
Alarge
percentage offemale NOD mice, including thoseofour own colony, develop sponta-
neous diabetes after 3 mo of age, whereas males from our colony rarely show the
disease and only after 6 mo ofage. To evaluate theagedependency ofthe protective
activity of spleen cells from nondiabetic female NOD mice, preirradiated male
recipients were injected at 24-h intervals with 20 x 106 spleen cells from nondia-
betic female NOD mice ofdifferent ages, then with 107 spleen cells from diabetic
NOD mice. As shownin Fig. 2, spleen cells from 8-wk-old nondiabetic female donors
provided the strongest protection against diabetes transfer as indicated by longest
delay in diabetes onset. By contrast, spleen cells from either 2-4-d- or 26-wk-old
NOD female mice provided no detectable protection and spleen cells from 2- and
5-wk-old mice only provided intermediate protective activity which, at 20 wks, was
not significantly different from that ofmice receiving no protective spleen cells or
spleen cells from 2-4-d or 26-wk-old animals. When considering reconstitution by
spleen cells from male NOD mice (Fig. 3), some protection was detected as soon
as by 2-4 d of age and up to 8 wk ofage as indicated by a significantly longer delay
in diabetes onset upon reconstitution with corresponding cells as compared with
nondiabetic spleen cells from 26-wk-old male mice.
Protective Activity ofSpleen Cells is Mediated by CD4+ TCells.
￿
To determine the role
ofspleen T cells in the protection provided by spleen cells from nondiabetic NOD
mice, the protective effect ofspleen cells depleted ofwhole T cells or T cell subsets
from 8-wk-old female NOD mice was evaluated. As shown in Fig. 4, CD8+-depleted
spleen cells conferred as strong a protection againstdiabetes transfer as total spleen
cell. By contrast, Thy-1.2+ depleted and CD4+-depleted spleen cells lost any detect-
able protective activity against diabetes transfer, supporting the role ofCD4+ T cellsBOITARD ET AL.
￿
1673
FIGURE 2 .
￿
Incidence of successful
transfer ofdiabetes into irradiated
(750 rad) 8-wk-old male NOD re-
cipients injected intravenouslywith
20 x 106 spleen cells collected from
nondiabetic female NOD mice of
2-4 d (O), 2 wk ("), 5 wk (à), 8
wk (A), and26 wk (p)ofage 24 h
before the transfer of 10 7 diabeto-
genic spleen cells . Acontrol group
(0) received no spleen cells from
nondiabetic donors although receiv-
ing 10 7 diabetogenic spleen cells
48 h after irradiation. Numbers
next to lines indicate the number
ofdiabetic recipients over the total
number ofanimals in each experi-
mental group .The difference inthe
incidence of transferred diabetes
was statistically significant when
comparing the control group with
recipients receiving spleen cells
from nondiabetic donors of8wk of
age at 20 wk .
in the protection . When considering 8-wk-old male donors the same trend was ob-
served pointing to the role of CD4+ cells in protection although the onset of dia-
betes upon transfer was only very transiently delayed as previously noted with total
male spleen cells (Fig . 5) .
Protective Activity of Thymic Cells.
￿
To determine the protective capacity of thymic
cells, preirradiated male recipients were transferred with 10 1 diabetogenic spleen
cells 24 h after reconstitution with thymic cellsfrom female nondiabeticNOD donors
FIGURE 3 .
￿
Incidence of suc-
cessful transfer of diabetes into
irradiated (750 rad) 8-wk-old
male NOD recipients injected
intravenously with 20 x 106
spleen cells collected from non-
diabetic male NOD mice of
2-4d (O), 2 wk ("), 5 wk (à),
8wk (A), and 26 wk (Q)ofage
24 h before the transfer of 10 7
diabetogenic spleen cells. Num-
bers next to lines indicate the
number of diabetic recipients
overthe totalnumberofanimals
in each experimental group .
The mean delay in diabetes
onset in mice reconstituted with
spleen cells from 26-wk-olddo
nors was 3.2 t 0.2 (SE) weeks and significantly higher in mice reconstituted with spleen cells from
2-4-d (6.8 t 1.4,p< 0.05) 2-wk- (6.3 t 1.1, p< 0.05), 5-wk- (8 .0 t 3.3, p < 0.01), or 8-wk-old (7 .2
± 0.05, p < 0.001) nondiabetic male NOD mice .1674
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FIGURE 4 .
￿
Incidence of suc-
cessful transfer ofdiabetes into
irradiated (750 rad) 8-wk-old
male recipients injected intra-
venously with 20 x 106 spleen
cells from 8-wk-old nondiabet-
ic NOD female donors either
treated with complement alone
(A), with antiThy-1 .2mAb (0),
anti-CD4 mAb (O), anti-CD8
mAb (p) plus complement . A
control group (A) received a
reconstituted population of
spleen cells obtained by added
CD4- and CD8- spleen cells in
respective proportions equiva-
lent to that of total spleen cells
from normal 8-wk-oldNOD fe
male mice. Numbers next to lines indicate the number of diabetic recipients over the total number of
animals in each experimental group. The difference between groups receiving CD8'-depleted spleen
cells, total, or reconstituted spleen cells and groups receiving either Thy-1,2' (p < 0.5 from week 11
to 17) or CD4'-depleted (p < 0.01 from week 11 to 17) spleen cells were statistically significant .
ofvarious ages as previously reported with spleen cells . A significant protectionwas
obtained with thymic cells from 2-4 d-, 2-wk-, and 8-wk-old mice . Some protection
was still detected, although to a lesser extent, with thymic cells from 5-wk-, or 26-
wk-old mice (Fig . 6) . Conversely, no clear protection was observed when using thymic
cells from male donors ofsame ages at 8 wk after transfer (Table II) . The difference
in the incidence of diabetes observed when comparing groups of animals reconstituted
with male and female thymic cells was statistically significant at 8 wk after transfer
in the 2-4-d and 8-wk groups, although not in the other age groups .
Protectiae Capacity of Spleen Cells after Thymectomy.
￿
To further investigate the role
of the thymus in the induction of protective cells, 20 x 106 spleen cells from nondi-
FIGURE 5 . Incidence of suc-
cessful transfer of diabetes into
irradiated (750 rad) 8-wk-old
male recipients injected intra-
venously with 20 x 106 spleen
cells from 8-wk-old nondiabetic
NOD male donors either treated
with complement alone (A),
with antiThy-1 .2 mAb (" ),
anti-CD4 mAb ((D), anti-CD8
mAb (p) plus complement . A
control group (0) received no
spleen cells from 8-wk-old non-
diabetic donors . Numbers next
to lines indicate the number of
diabetic recipients over thetotal
number of animals in each ex-
perimental group .BOITARD ET AL .
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FIGURE 6 .
￿
Incidence of suc-
cessful transfer ofdiabetes into
irradiated (750 rad) 8-wk-old
male NOD recipients injected
intravenously with 20 x 10 6
thymic cells collected from non-
diabetic femaleNOD mice aged
2-4 d (O), 2wk (" ), 5 wk (A),
8 wk (A), and 26 wk (p) 24 h
before the transfer of 107 di-
abetogenic spleen cells . A con-
trol group (0) received no thy-
mic cells from nondiabetic
donors, although it received 107
diabetogenic thymic cells 48 h
after irradiation. A group (*)
was injected with spleen cells
from nondiabetic male NOD
mice of 2-4 d, as in Fig. 3 . Numbers next to lines indicate the number of diabetic recipients over the
total number of animals in each experimental group. The difference in the incidence of transferred
diabetes was statistically significant when comparing recipients receiving thymic cells from nondiabetic
donors aged 2-4 days, 2 wk, and 8 wk and the control group receiving no lymphoid cells (P < 0.01)
at the end of the experiment.
TABLE II
Protective Activity against Diabetes Transfer of Thymic Cells
from Male Nondiabetic NOD Mice
" 20 x 106 thymic cells were injected intravenously into preirradiated recipients .
Recipients were 8-wk-old male NOD mice injected intravenously with thymic cells 24 h af-
ter irradiation, then 24 h later with 10 7 diabetogenic spleen cells from diabetic NOD mice .
$ The difference was statistically significant between the group receiving no thymic cells and
groups receiving thymic cells from 2-4-d- (p < 0.01), 2-wk- (p < 0.05), or 8-wk- (p < 0.05)
old male nondiabetic NOD donors .
II No significant difference was observed between the group receiving no thymic cells and that
receiving thymic cells from male NOD donors of various ages .
abetic 8-wk-old donors that had been thymectomized or sham thymectomized at
weaning were used as protector cells to reconstitute irradiated recipients . As shown
in Fig . 7, thymectomy completely abrogated the capacity of spleen cells from 8-wk-
old female donors to confer protection against diabetes transfer. Spleen cells from
sham-thymectomized female donors showed full protective activity. Interestingly,
thymectomy of male donors did not influence the protective effect of spleen cells .
Age of donors
of thymic cells*
Sex of donors
of thymic cells
Number of
4 wk after transfer§
diabetic recipientst
8 wk after transferdl
2-4 d Male 0/6 6/6
2 wk Male 1/6 4/6
5 wk Male 5/7 6/7
8 wk Male 1/7 6/7
26 wk Male 5/5 5/5
No thymic cells - 5/5 5/51676
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100
0 10 Age (weeks) 20
FIGURE 7.
￿
Incidence of suc-
cessful transfer of diabetes into
irradiated (750 rad) 8-wk-old
male NOD recipients injected
intravenously with 20 x 106
spleen cells collected from non-
diabetic female (Q, 0) or male
([I, N) thymectomized (" , ")
or sham thymectomized (Q, O)
at weaning. Numbers next to
lines indicate the number ofdia-
betic recipients over the total
number of animals in each ex-
perimental group. A statistically
significant difference was ob-
served between groups receiv-
ing spleen cells from thymecto-
mized and sham-thymectomized
female NOD donors (p < 0.001),
although not between those re-
ceiving corresponding spleen
cells from male NOD donors.
Discussion
NOD mice show a high incidence ofinsulin-dependent diabetesthat is much higher
in females than in males (1). The central role of T cells in the pathogenesis of the
disease is indicatedby the infiltration ofpancreaticßcellsby Tcells(2, 3), the preven-
tion ofthe disease by neonatal thymectomy (4) or treatment with anti-T cell mAbs
(6, 7) and the transfer of the disease into syngeneic healthy recipients by T cells
obtained from diabetic mice (9-11). The absence of a pathogenic role of autoanti-
bodies is suggested by the successful transfer ofthe disease intoneonatal NODmice
rendered agammaglobulinemic by treatment with anti-p, antibody (13). However,
the mechanism of T cell intervention in the NOD mouse is not clear. Both CD4'
and CD8' T cell subsets are necessary to transfer the disease (9, 11). One may as-
sume that T cells are involved at both the effector and regulatory levels but little
is known ofthe respective role ofthe T cell subsets involved in cellular interactions
responsible forthe development ofantiislet immunity. We report here data that sug-
gest a role for T cell-mediated suppression.
The basis ofour work was to obtain a model ofaccelerated disease by taking ad-
vantage ofthe low incidence ofspontaneous IDDM in male NOD mice and of the
high susceptibility ofmales to disease transfer. Thetransferofdiabetes in male NOD
recipients was thus used as an assay system for studying protection by various lym-
phoid cell populations. We observed that lymphoid cells from nondiabetic NOD
mice (taken before the onset ofdiabetes) can delay or suppress the transfer ofdia-
betes afforded by spleen cells from overtly diabetic mice into sublethally irradiated
NOD recipients. This suppressive activity was detected whenever male or female
8-wk-old recipient mice were considered although the onset of diabetes was more
delayed in male than in female recipients. This may reflect thehigher susceptibility
to spontaneous diabetes in female than male NOD mice and simple acceleration
ofthedisease process upon transferofspleen cells from diabetic mice in female NOD
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mice. Such higher susceptibility in female than in male recipients has been clearly
evidenced upon transfer of diabetogenic spleen cells into NOD neonates (9).
The protection is mediated by CD4+ T cells since it is abrogated by in vitro treat-
ment of spleen cells by antiThy-1,2 and anti-CD4 antibody plus complement but
not by anti-CD8 antibody plus complement. The role of the thymic gland with re-
gard to this suppressive activity is indicated by theirabsencein female mice thymec-
tomized at weaning (3 wk of age) and by the early and potent protective activity
of thymocytes. Ourdata indicate that theprotective activity detected in spleen cells
reaches its highest level at 8 wk of age in nondiabetic NOD mice. This protective
activity is undetectable in spleen cells although it is detected in thymic cells in neo-
nates. The data obtained in thymectomized mice indicate that migration of pro-
tector T cells from the thymus is probably at the origin of the suppressor CD4+
cells detected in the spleen, but it mainly occurs during the first 8 wk of life since
suppression is detectable in the thymus at birth but not in the spleen until 8 wk
of age. Prevention of diabetes by neonatal thymectomy is not in contradiction with
our observations since it abrogates not only thymic suppressor T cells but also the
generation of effector T cells responsible for the ultimate development of diabetes.
The mechanism of the suppression is not clear but does not involve activation of
protective cells by Y -encoded minor histocompatibility antigens expressed on male
cells, since it is observed in male/male or female/female combinations. It is also un-
likely that it is secondary to competition forcell homing, since when identical numbers
of spleen cells are used, no protection is observed with those from 8-wk-old NOD
male mice, whereas cells from 8-wk-old NOD female mice are protective. The
CD4+ phenotype of the protector cells is reminiscent of previous data showing the
suppressive activity of CD4+ cells (whether directly mediated by these cells or after
induction of a second T cell subset, possibly CD8+), including in autoimmune dis-
eases induced in animals against erythrocytes (19), myelin basic protein (20), or
thyroglobulin (21). We recently demonstrated that injection ofmAbs directed against
class II MHC protects NOD mice from diabetes through the induction of CD4+
suppressor T cells (8).
In contrast with protection against clinical diabetes, no protection was observed
against insulitis. Such discordance is reminiscent of the absence of a clear relation
between the constant presence of insulitis in both male and female mice and the
inconstant developmentof ultimate diabetes that predominates in female NOD mice
(2, 3). Moreover, insulitis is observed as early as 4 wk of age, long before the devel-
opment of hyperglycemia (2, 3). The significance of the insulitis transferred in
recipients protected againstclinical diabetes after reconstitution by spleen cellsfrom
nondiabetic donors was not investigated since no cellular marker is presently avail-
able to follow diabetogenic and protecting cells in recipient animals.
Indirect evidence has been interpreted as indicating that suppressor phenomena
could control the development of autoimmunity in NOD mice. Irradiation of recip-
ient NOD mice older than 3 wk of age is necessary to successfully transfer the dis-
ease by injecting spleen cells from diabetic mice (10). Cyclophosphamide induces
diabetes in prediabetic NOD mice, an effect that possibly involves elimination of
suppressor cells (18, 22). It is interesting to note that spleen cells from cyclophos-
phamide-treated mice can transfer diabetes into syngeneic preirradiated recipients,1678
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bringing strong evidence against a direct effect ofcyclophosphamide on target insulin-
secreting cells (22). Last, thymectomy at weaning accelerates the onset ofdiabetes
in female (but not in male) NOD mice (Dardenne, M., et al., manuscript inprepa-
ration). Such indirect indications that suppressor T cells are at play in the develop-
ment ofNOD mouse diabetes are concordant with our observation that spleen cells
from nondiabetic mice can protect against diabetes transfer. One should note, how-
ever, that cyclophosphamide doses required to induce diabetes (150-200 mg x 2)
(18) or irradiation doses allowing transfer of the disease (more than 550 rad) are
higher than those reported to selectively abrogate suppressor T cells. It must thus
behypothesized that theeffect ofcyclophosphamide orirradiation in the NOD mouse
model is not limited to suppressor T cells as detected in our assay.
The relatively higher suppressive activity detected in our assay system in female
than in male NODmicehas to be reconciled withthe higher susceptibilityoffemale
than male mice tospontaneous onset ofdiabetes. One possible interpretation is that
the suppressive activity we report is not responsible for the lowerincidence ofspon-
taneous diabetes in male mice. The high level ofprotection detected in ourtransfer
assaycould be related tothe high susceptibility to development ofdiabetes in female
animals, which would lead to the hypothesis that emergence of suppressor cells in
female NOD mice, although providing efficient but transientprotection, is secondary
to a more profound defect ofphysiological tolerance to islet autoantigens. Anti-(3
cell effector (or helper) T cells could enhance the subsequent generation ofprotec-
tive cells. The cellular basis of the male resistance to diabetes would then remain
to be explained possibly by a less efficient effector or helper T cell function.
A key unsolved issue in this discussion is the antigen specificity ofthe suppressor
Tcells detected in female NOD mice. The question remains open due to the lack
of knowledge ofthe 0 cell autoantigen. The determination of such specificity will
be crucial, however, both for the understanding of the pathophysiological basis of
the suppressor effect with regard to the potential therapeutic implications of such
an experimental approach.
Summary
The nonobese diabetic (NOD) mouse has recently been introduced as a model
for insulin-dependent diabetes mellitus. The role ofregulatory T cells in the devel-
opment ofantipancreatic autoimmunity in this model remains unclear. Toevaluate
the presence ofsuppressive phenomena, we used disease transferby spleen cells from
diabetic NOD mice into preirradiated adult recipients as a model for accelerated
disease. Suppressor phenomena were detected by testing the protection afforded by
lymphoid cells from nondiabetic NOD mice against diabetes transfer in irradiated
recipients. Transferofdiabetes was delayed by reconstituting recipients with spleen
cells from nondiabetic NOD donors. The greatest protection againstdiabetes transfer
was conferred by spleen cells from8-wk-old nondiabetic female NOD mice. Deple-
tion experiments showed that the protection was dependent on CD4+ cells. Protec-
tion was also detected within thymic cells from nondiabetic NOD mice and protec-
tion conferred by spleen cells was abrogated by thymectomy ofnondiabetic female,
but not male, NOD donors at 3 wk ofage. These findings indicate that suppressive
CD4+ T cells that are dependent on the presence ofthe thymus may delay the onset
of diabetes in female diabetes-prone NOD mice.BOITARD ET AL.
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